<DOC>
	<DOCNO>NCT00436527</DOCNO>
	<brief_summary>This eight-hour kinetic regression clinical study conduct assess ability MetroGel® 1 % deliver moisture facial skin single application .</brief_summary>
	<brief_title>Assess Ability MetroGel 1 % Deliver Moisture Facial Skin After Single Application</brief_title>
	<detailed_description>This eight-hour kinetic regression clinical study conduct assess ability MetroGel® 1 % deliver moisture facial skin single application measure Corneometer CM 825 .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Clinical diagnosis moderate severe rosacea , define presence least moderate erythema telangiectasia minimum two inflammatory lesion Individuals active symptom allergy ( mild active seasonal allergy acceptable ) atopic dermatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>